Gilead’s promising COVID-19 drug remdesivir shows benefit in 68% of hospitalised patients
April 14, 2020Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir
Gilead has provided an update on its ongoing efforts against the novel coronavirus, revealing data from a cohort analysis of …
Fatal heart complications halt Brazilian study of chloroquine in treating COVID-19
April 14, 2020Manufacturing and Production COVID-19, chloroquine, hydroxychloroquine
A chloroquine study investigating its effects in treating the COVID-19 coronavirus in Brazil has been postponed for safety reasons. It …
Pharmafile.com’s weekly COVID-19 news round-up
April 9, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus
The world looks for a coronavirus cure as Inovio begins human trials for a vaccine while another vaccine is in …
Seres Therapeutics appoints Dr Lisa von Moltke as new Chief Medical Officer
April 9, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Dr Lisa von Moltke has left Aklermes and has joined Seres Therapeutics as its new Chief Medical Officer. Chief Executive …
Circassia terminates AstraZeneca partnership in exchange for £150m debt settlement
April 9, 2020Sales and Marketing AstraZeneca, Circassia, partnership, pharma, respiratory
Circassia Pharmaceuticals has announced its decision to break away from a partnership it forged with AstraZeneca UK back in 2017 …
Pfizer and Eli Lilly defeat lawsuit over claims Viagra and Cialis cause cancer
April 9, 2020Business Services Pfizer, viagra
Pfizer and Eli Lilly have defeated a class action lawsuit seeking billions in damages over claims that Viagra and Cialis …
US reports increase in Hydroxychloroquine misuse
April 9, 2020Business Services COVID-19, Donald Trump, coronavirus, hydroxychloroquine
The American Association of Poison Control Centers (AAPCC) has said there has been an increase in people abusing the anti-malaria …
Roche signs multi-billion dollar RNA-targeted drug discovery deal with Arrakis Therapeutics
April 9, 2020Research and Development, Sales and Marketing Arrakis, Roche, partnership, pharma
Roche has signed a new partnership with Arrakis Therapeutics in a bid to drive discovery of RNA-targeted small molecule (rSM) …
Envision Pharma Group acquires healthcare comms consultancy 90TEN
April 9, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 90TEN, Envision Pharma Group, pharma
Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group, it has been revealed. 90TEN said that it …
Dr Maritza McIntyre appointed Chief Development Officer at StrideBio
April 8, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
StrideBio have announced the appointment of Maritza McIntyre Ph.D., as its first Chief Development Officer. The newly created role will …
Sage Therapeutics to halve its total workforce in radical cost-cutting move
April 8, 2020Research and Development, Sales and Marketing Sage Therapeutics, pharma, staff cuts
Sage Therapeutics has revealed a radical restructuring effort to cut costs and “enable the company to advance its corporate strategy …
COVID-19 less severe in paediatric patients, according to the CDC
April 8, 2020Research and Development COVID-19, coronavirus
The Centers for Disease Control and Prevention (CDC) confirms that COVID-19 is less severe in children than adults. The report, …
Eli Lilly will limit insulin costs to $35 per month for patients in the US due to COVID-19
April 8, 2020Research and Development Eli Lilly, diabetes, insulin
Eli Lilly announced that it will limit out of pocket costs for insulin to $35 per month to offset the …
Second Genome to help drive development of Gilead therapies in potential $1.5bn deal
April 8, 2020Research and Development Gilead, Second Genome, pharma
Gilead and microbiome science specialist Second Genome have announced they are to partner up to advance a selection of the …
Critics say Trump pushing hydroxychloroquine due to his financial ties to manufacturers
April 8, 2020Research and Development COVID-19, coronavirus, covid 19, hydroxychloroquine
Critics are arguing that President Donald Trump is touting the malaria drug hydroxychloroquine as a COVID-19 treatment because he has …
Inovio’s coronavirus vaccine, funded by Bill Gates, begins human trials
April 7, 2020Manufacturing and Production COVID-19, coronavirus, coronavirus vaccine
Inovio’s coronavirus vaccine has entered human trials after the FDA approved its application to begin them under the Investigational New …
Martin Shkreli asks to be furloughed from prison to work on COVID-19 treatments
April 7, 2020Manufacturing and Production COVID-19, Pharma Bro, coronavirus
Disgraced biotech entrepreneur Martin Shkreli, also known as the ‘Pharma Bro’, is asking for a brief furlough from prison to …
Incyte’s ruxolitinib cream formulations look strong in Phase 3 atopic dermatitis
April 7, 2020Manufacturing and Production, Research and Development Incyte, atopic dermatitis, ruxolitinib
Incyte has lifted the curtain on promising new Phase 3 data for its 0.75% and 1.5% twice daily cream formulations …
Donald Trump talks of “retaliation” if India does not export hydroxychloroquine to the US
April 7, 2020Manufacturing and Production American coronavirus, COVID-19, Donald Trump, coronavirus
United States President Donald Trump has suggested that the US may retaliate if India did not export the anti-malaria drug …
Takeda’s Alunbrig outclasses Xalkori to secure EU approval in ALK+ advanced non-small cell lung cancer
April 7, 2020Manufacturing and Production, Sales and Marketing Alunbrig, Europe, Takeda, pharma
The European Commission has ruled to expand the current approved indication of Takeda’s Alunbrig (brigatinib), authorising the drug as a …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
